BR0310003A - compostos peptìdeos e seu uso como substratos de protease - Google Patents

compostos peptìdeos e seu uso como substratos de protease

Info

Publication number
BR0310003A
BR0310003A BRPI0310003-0A BR0310003A BR0310003A BR 0310003 A BR0310003 A BR 0310003A BR 0310003 A BR0310003 A BR 0310003A BR 0310003 A BR0310003 A BR 0310003A
Authority
BR
Brazil
Prior art keywords
compounds
salts
protease
peptide compounds
substrates
Prior art date
Application number
BRPI0310003-0A
Other languages
English (en)
Inventor
Gary A Decrescenzo
Carol P Howard
Joseph G Rico
Kun Zhang
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Publication of BR0310003A publication Critical patent/BR0310003A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/60—Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2337/00—N-linked chromogens for determinations of peptidases and proteinases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"COMPOSTOS PEPTìDICOS E SEU USO COMO SUBSTRATOS DE PROTEASE". Esta invenção refere-se geralmente a compostos peptídicos e sais, e particularmente a compostos peptídicos e sais que são úteis como substratos de protease, como substratos metaloprotease de matriz ('MMP'). Esta invenção refere-se também a métodos para preparação de tais compostos e sais, bem como a aminoácidos que podem, por exemplo, ser usados nesses métodos. Esta invenção refere-se ainda a métodos para uso de tais compostos e sais para, por exemplo, avaliar a eficácia dos inibidores potenciais de protease e para detectar ou monitorar uma doença associada com atividade de protease.
BRPI0310003-0A 2002-05-10 2003-05-10 compostos peptìdeos e seu uso como substratos de protease BR0310003A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37959802P 2002-05-10 2002-05-10
PCT/US2003/014869 WO2003095475A2 (en) 2002-05-10 2003-05-10 Peptide compounds and their use as protease substrates

Publications (1)

Publication Number Publication Date
BR0310003A true BR0310003A (pt) 2007-04-10

Family

ID=29420543

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0310003-0A BR0310003A (pt) 2002-05-10 2003-05-10 compostos peptìdeos e seu uso como substratos de protease

Country Status (11)

Country Link
US (1) US20040018561A1 (pt)
EP (1) EP1504094A2 (pt)
JP (1) JP2005538946A (pt)
KR (1) KR20050034642A (pt)
AU (1) AU2003263736A1 (pt)
BR (1) BR0310003A (pt)
CA (1) CA2485437A1 (pt)
IL (1) IL165084A0 (pt)
MX (1) MXPA04011142A (pt)
PL (1) PL374438A1 (pt)
WO (1) WO2003095475A2 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007521254A (ja) * 2003-06-25 2007-08-02 ゲルベ 診断画像用化合物
US8968700B2 (en) * 2005-08-11 2015-03-03 The Board Of Trustees Of The Leland Stanford Junior University Imaging of protease activity in live cells using activity based probes
US8492098B2 (en) 2006-02-21 2013-07-23 The Trustees Of Tufts College Methods and arrays for target analyte detection and determination of reaction components that affect a reaction
US11237171B2 (en) 2006-02-21 2022-02-01 Trustees Of Tufts College Methods and arrays for target analyte detection and determination of target analyte concentration in solution
KR101016213B1 (ko) 2007-11-20 2011-02-25 한국과학기술연구원 단백질 분해효소의 영상화를 위한 소광된 형광 센서, 그제조 방법 및 용도
EP2475778B1 (en) 2009-09-09 2014-10-22 3M Innovative Properties Company Methods and kit for protease enzyme assays
US8236574B2 (en) 2010-03-01 2012-08-07 Quanterix Corporation Ultra-sensitive detection of molecules or particles using beads or other capture objects
WO2011109379A1 (en) 2010-03-01 2011-09-09 Quanterix Corporation Methods and systems for extending dynamic range in assays for the detection of molecules or particles
US9952237B2 (en) 2011-01-28 2018-04-24 Quanterix Corporation Systems, devices, and methods for ultra-sensitive detection of molecules or particles
WO2012142301A2 (en) 2011-04-12 2012-10-18 Quanterix Corporation Methods of determining a treatment protocol for and/or a prognosis of a patients recovery from a brain injury
US9932626B2 (en) 2013-01-15 2018-04-03 Quanterix Corporation Detection of DNA or RNA using single molecule arrays and other techniques
US9141906B2 (en) 2013-03-13 2015-09-22 Google Inc. Scoring concept terms using a deep network
CN105189465B (zh) 2013-03-21 2019-02-26 赛诺菲-安万特德国有限公司 合成含有乙内酰脲的肽产物
WO2014147129A1 (en) 2013-03-21 2014-09-25 Sanofi-Aventis Deutschland Gmbh Synthesis of cyclic imide containing peptide products
GB201504778D0 (en) 2015-03-20 2015-05-06 Univ Edinburgh Optical probes for matrix metalloproteinases
KR102007078B1 (ko) * 2017-03-24 2019-08-05 (주)셀아이콘랩 콜라겐 생성을 촉진시키는 신규한 헵타펩타이드 단량체 및 이량체를 포함하는 피부 노화 방지를 위한 화장품 조성물
KR101989666B1 (ko) * 2017-03-24 2019-06-17 (주)셀아이콘랩 신규한 헵타펩타이드 단량체 및 이량체를 포함하는 피부노화 또는 피부주름 예방, 개선을 위한 화장료 조성물
KR102007077B1 (ko) * 2017-03-24 2019-08-06 (주)셀아이콘랩 피부 노화 방지 및 피부 주름 예방용 펜타펩타이드와 펜타펩타이드 다이머의 제조방법과 이를 포함하는 화장료 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997025437A1 (en) * 1996-01-04 1997-07-17 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Method for assaying proteolytic enzymes using fluorescence-quenched substrates
AU2002230630A1 (en) * 2000-11-08 2002-05-21 Beth Israel Deaconess Medical Center, Inc. Methods for determining protease cleavage site motifs

Also Published As

Publication number Publication date
IL165084A0 (en) 2005-12-18
EP1504094A2 (en) 2005-02-09
US20040018561A1 (en) 2004-01-29
AU2003263736A1 (en) 2003-11-11
WO2003095475A8 (en) 2004-06-10
JP2005538946A (ja) 2005-12-22
PL374438A1 (en) 2005-10-17
CA2485437A1 (en) 2003-11-20
WO2003095475A2 (en) 2003-11-20
AU2003263736A2 (en) 2003-11-11
KR20050034642A (ko) 2005-04-14
WO2003095475A3 (en) 2004-08-26
MXPA04011142A (es) 2005-02-17

Similar Documents

Publication Publication Date Title
BR0310003A (pt) compostos peptìdeos e seu uso como substratos de protease
CY1111225T1 (el) Νεα πεπτιδια ως αναστολεις πρωτεασης νs3-σερινης ιου ηπατiτιδας c
BR0112540A (pt) Peptìdios como inibidores da ns-3-serina protease do vìrus da hepatite c
BR0009167A (pt) Inibidores de enzima impdh
NZ596269A (en) Protease screening methods and proteases identified thereby
MX9207449A (es) Inhibidores de la enzima proteolitica derivada de sacarina.
ECSP045520A (es) Metodos de tratamiento con inhibidores de la ptec y agentes antihipertensivos
BR0112666A (pt) Peptìdeos como inibidores de ns3-serina protease de vìrus da hepatite c
BR0108750A (pt) Variantes da xilanase que apresentam sensibilidade alterada para inibidores da xilanase
MX2010004371A (es) Proteasa de streptomyces.
UY30984A1 (es) Proteinas de fusion de formula m-a para degradar péptidos beta amiloides, composiciones en base a ella, preparacion y aplicaciones.
TR199902751T2 (xx) Proteaz inhibit�rleri.
ES2051702T3 (es) Derivados peptidicos y metodo para medir la actividad de sustancias fisiologicamente activas usandolos como sustratos.
BRPI0519148A2 (pt) inibidores de homodimerizaÇço de myd88
BRPI0507971A (pt) composto, composição farmacêutica, uso de um composto,método para inibir a atividade proteolìtica de uma enzima de clivagem pós-prolina e remédio empacotado
ATE292801T1 (de) Verfahren zum screening von inhibitoren von asp2
BR0302496A (pt) Composições farmacêuticas com atividade antibiótica
BR0306928A (pt) Composições farmacêuticas estáveis compreendendo inibidores de enzimas conversoras de angiotensina (ace)
ATE131066T1 (de) Mittel zur hemmung von hiv-proteasen.
BR9912519A (pt) Variantes estabilizadas de inibidor de subtilisina de streptomyces
CA2549185A1 (en) Peptide inhibiting angiotensin converting enzyme
BRPI0513267A (pt) variantes melhoradas de aprotinina
BRPI0409557A (pt) proteìna inibidora recombinante de calicreìna, seqüência de dna, vetor de expressão, célula hospedeira, composição farmacêutica e seu uso, método de produção de proteìna inibidora recombinante de calicreìna e kit de diagnóstico para detecção de calicreìna
BR0112543A (pt) Derivados hidrazìdicos do ácido pirrolidino-2-carboxìlico para uso como inibidores de metaloproteases
BRPI0408778A (pt) proteìnas ativadoras de elemento de resposta à amp cìclica e uso relacionado as mesmas